Kangmei Pharma | 600518 - Current Liabilities


Kangmei Pharma reported CNY5.81B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 133.38M 14.66M Sep/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.6M 42.44M Jun/2025
Cspc Pharmaceutical CNY 10.11B 478.47M Jun/2025
Dianthus Therapeutics USD 23.86M 3.76M Sep/2025
Genomma Lab Internacional MXN 6.98B 287.5M Sep/2025
Hypermarcas BRL 4.96B 523.21M Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Jiangsu Hengrui CNY 7.85B 4.39B Sep/2025
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Sh Fosun Pharma CNY 35.09B 936.39M Sep/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Viatris USD 7.36B 230.7M Sep/2025
Wuxi Apptec CNY 19.44B 1.08B Sep/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025